| Cost-effectiveness of exenatide twice daily vs insulin glargine as add-on therapy to oral antidiabetic agents in patients with type 2 diabetes in China | |
| Gu, Shuyan; Wang, Xiaoyong; Qiao, Qing; Gao, Weiguo; Wang, Jian; Dong, Hengjin | |
| 刊名 | DIABETES OBESITY & METABOLISM
 |
| 2017 | |
| 卷号 | 19期号:12页码:1688-1697 |
| 关键词 | antidiabetic drug cost-effectiveness exenatide insulin therapy type 2 diabetes pharmaco-economics |
| DOI | 10.1111/dom.12991 |
| URL标识 | 查看原文 |
| 公开日期 | [db:dc_date_available] |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4592814 |
| 专题 | 山东大学 |
| 作者单位 | Zhejiang Univ, Ctr Hlth Policy Studies, Sch Publ Hlth, Sch Med, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R Ch |
| 推荐引用方式 GB/T 7714 | Gu, Shuyan,Wang, Xiaoyong,Qiao, Qing,et al. Cost-effectiveness of exenatide twice daily vs insulin glargine as add-on therapy to oral antidiabetic agents in patients with type 2 diabetes in China[J]. DIABETES OBESITY & METABOLISM,2017,19(12):1688-1697. |
| APA | Gu, Shuyan,Wang, Xiaoyong,Qiao, Qing,Gao, Weiguo,Wang, Jian,&Dong, Hengjin.(2017).Cost-effectiveness of exenatide twice daily vs insulin glargine as add-on therapy to oral antidiabetic agents in patients with type 2 diabetes in China.DIABETES OBESITY & METABOLISM,19(12),1688-1697. |
| MLA | Gu, Shuyan,et al."Cost-effectiveness of exenatide twice daily vs insulin glargine as add-on therapy to oral antidiabetic agents in patients with type 2 diabetes in China".DIABETES OBESITY & METABOLISM 19.12(2017):1688-1697. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论